Professor of Radiotherapeutics and Radioimaging
- Group Leader, Oxford Institute for Radiation Oncology
- Honorary Consultant in Clinical Oncology, Oxford University Hospitals NHS Trust
My research is interested in personalising radiotherapy using functional imaging: we apply functional and molecular imaging techniques to developing radiotherapy personalised to each patients’ individual tumour biology.
Katherine undertook specialist training in Clinical Oncology at the Hammersmith Hospital and doctoral research at Edinburgh University. In 1995 she was appointed as Staff Radiation Oncologist at the Princess Margaret Hospital and Scientist at the Ontario Cancer Institute, Toronto. She returned to the UK in 2006 to join the Oxford Institute and establish the Radiotherapeutics and Radioimaging Group.
Malcolm J. et al, (2019), Cancers (Basel), 11
Gill MR. and Vallis KA., (2019), Chem Soc Rev, 48, 540 - 557
Kazmi F. et al, (2018), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102, E184 - E184
Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study
McGowan DR. et al, (2018)
Teoh S. et al, (2018), JOURNAL OF THORACIC ONCOLOGY, 13, S1027 - S1027